Cytokinetics (CYTK) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $77.49 +0.95%
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
TISI, VGAS, GBR, More
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
TISI, VGAS, GBR, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q4 EPS of ($0.24), $0.08 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $10.49 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TTEC Holdings (TTEC) Misses Q2 EPS by 22c ; Offers Guidance
- Infinity Natural Resources, Inc. (INR) Tops Q2 EPS by 11c
- New Concept Energy (GBR) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
